187 related articles for article (PubMed ID: 23550714)
1. The European Medicines Agency approval of 5-aminolaevulinic acid (Ameluz) for the treatment of actinic keratosis of mild to moderate intensity on the face and scalp: summary of the scientific assessment of the Committee for Medicinal Products for Human Use.
Tzogani K; Straube M; Hoppe U; Kiely P; O'Dea G; Enzmann H; Salmon P; Salmonson T; Pignatti F
J Dermatolog Treat; 2014 Oct; 25(5):371-4. PubMed ID: 23550714
[TBL] [Abstract][Full Text] [Related]
2. The European Medicines Agency approval of ingenol mebutate (Picato) for the cutaneous treatment of non-hyperkeratotic, non-hypertrophic actinic keratosis in adults: summary of the scientific assessment of the Committee for Medicinal Products for Human Use (CHMP).
Tzogani K; Nagercoil N; Hemmings RJ; Samir B; Gardette J; Demolis P; Salmonson T; Pignatti F
Eur J Dermatol; 2014; 24(4):457-63. PubMed ID: 25115145
[TBL] [Abstract][Full Text] [Related]
3. A randomized, double-blind, phase III, multicentre study to evaluate the safety and efficacy of BF-200 ALA (Ameluz(®) ) vs. placebo in the field-directed treatment of mild-to-moderate actinic keratosis with photodynamic therapy (PDT) when using the BF-RhodoLED(®) lamp.
Reinhold U; Dirschka T; Ostendorf R; Aschoff R; Berking C; Philipp-Dormston WG; Hahn S; Lau K; Jäger A; Schmitz B; Lübbert H; Szeimies RM
Br J Dermatol; 2016 Oct; 175(4):696-705. PubMed ID: 26921093
[TBL] [Abstract][Full Text] [Related]
4. Combined daylight and conventional photodynamic therapy with 5-aminolaevulinic acid nanoemulsion (BF-200 ALA) for actinic keratosis of the face and scalp: a new and efficient approach.
Salido-Vallejo R; Jiménez-Nájar F; Garnacho-Sucedo G; Vélez A
Arch Dermatol Res; 2020 Nov; 312(9):675-680. PubMed ID: 31838569
[TBL] [Abstract][Full Text] [Related]
5. Pain during topical photodynamic therapy - comparing methyl aminolevulinate (Metvix
Yazdanyar S; Zarchi K; Jemec GBE
Photodiagnosis Photodyn Ther; 2017 Dec; 20():6-9. PubMed ID: 28780136
[TBL] [Abstract][Full Text] [Related]
6. A randomized intraindividual comparative study of methyl-5-aminolaevulinate vs. 5-aminolaevulinic acid nanoemulsion (BF-200 ALA) in photodynamic therapy for actinic keratosis of the face and scalp.
Serra-Guillén C; Nagore E; Bancalari E; Kindem S; Sanmartín O; Llombart B; Requena C; Serra-Guillén I; Calomarde L; Diago A; Bernia E; Guillén C
Br J Dermatol; 2018 Dec; 179(6):1410-1411. PubMed ID: 30019337
[No Abstract] [Full Text] [Related]
7. Photodynamic therapy with BF-200 ALA for the treatment of actinic keratosis: results of a multicentre, randomized, observer-blind phase III study in comparison with a registered methyl-5-aminolaevulinate cream and placebo.
Dirschka T; Radny P; Dominicus R; Mensing H; Brüning H; Jenne L; Karl L; Sebastian M; Oster-Schmidt C; Klövekorn W; Reinhold U; Tanner M; Gröne D; Deichmann M; Simon M; Hübinger F; Hofbauer G; Krähn-Senftleben G; Borrosch F; Reich K; Berking C; Wolf P; Lehmann P; Moers-Carpi M; Hönigsmann H; Wernicke-Panten K; Helwig C; Foguet M; Schmitz B; Lübbert H; Szeimies RM;
Br J Dermatol; 2012 Jan; 166(1):137-46. PubMed ID: 21910711
[TBL] [Abstract][Full Text] [Related]
8. Effective photodynamic therapy of actinic keratoses on the head and face with a novel, self-adhesive 5-aminolaevulinic acid patch.
Hauschild A; Popp G; Stockfleth E; Meyer KG; Imberger D; Mohr P; Itschert G; Kaufmann R; Neuber K; Frambach Y; Gollnick H; Brunnert M; Stocker M; Ortland C; Karrer S
Exp Dermatol; 2009 Feb; 18(2):116-21. PubMed ID: 18643849
[TBL] [Abstract][Full Text] [Related]
9. Comparison of 10 efficient protocols for photodynamic therapy of actinic keratosis: How relevant are effective light dose and local damage in predicting the complete response rate at 3 months?
Vignion-Dewalle AS; Baert G; Thecua E; Lecomte F; Vicentini C; Abi-Rached H; Mortier L; Mordon S
Lasers Surg Med; 2018 Jul; 50(5):576-589. PubMed ID: 29667728
[TBL] [Abstract][Full Text] [Related]
10. Comparative study of trichloroacetic acid vs. photodynamic therapy with topical 5-aminolevulinic acid for actinic keratosis of the scalp.
Di Nuzzo S; Cortelazzi C; Boccaletti V; Zucchi A; Conti ML; Montanari P; Feliciani C; Fabrizi G; Pagliarello C
Photodermatol Photoimmunol Photomed; 2015 Sep; 31(5):233-8. PubMed ID: 25660106
[TBL] [Abstract][Full Text] [Related]
11. Photodynamic therapy simplified: nonprepared, moderate-grade actinic keratosis lesions respond equally well to 5-aminolaevulinic acid patch photodynamic therapy as do mild lesions.
Szeimies RM; Hauschild A; Ortland C; Moor AC; Stocker M; Surber C
Br J Dermatol; 2015 Nov; 173(5):1277-9. PubMed ID: 25940103
[No Abstract] [Full Text] [Related]
12. Simulated-daylight photodynamic therapy with BF-200 aminolaevulinic acid for actinic keratosis: assessment of the efficacy and tolerability in a retrospective study.
Kellner C; Bauriedl S; Hollstein S; Reinhold U
Br J Dermatol; 2015 Apr; 172(4):1146-8. PubMed ID: 25244353
[No Abstract] [Full Text] [Related]
13. A randomized multicenter study to compare two treatment regimens of topical methyl aminolevulinate (Metvix)-PDT in actinic keratosis of the face and scalp.
Tarstedt M; Rosdahl I; Berne B; Svanberg K; Wennberg AM
Acta Derm Venereol; 2005; 85(5):424-8. PubMed ID: 16159735
[TBL] [Abstract][Full Text] [Related]
14. [Retrospective, descriptive, observational study of treatment of multiple actinic keratoses with topical methyl aminolevulinate and red light: results in clinical practice and correlation with fluorescence imaging].
Fernández-Guarino M; Harto A; Sánchez-Ronco M; Pérez-García B; Marquet A; Jaén P
Actas Dermosifiliogr; 2008 Dec; 99(10):779-87. PubMed ID: 19091216
[TBL] [Abstract][Full Text] [Related]
15. Continuous ultra-low-intensity artificial daylight is not as effective as red LED light in photodynamic therapy of multiple actinic keratoses.
Wiegell SR; Heydenreich J; Fabricius S; Wulf HC
Photodermatol Photoimmunol Photomed; 2011 Dec; 27(6):280-5. PubMed ID: 22092730
[TBL] [Abstract][Full Text] [Related]
16. Treatment of Actinic Keratosis with Photodynamic Therapy Using Red or Green Light: A Comparative Study.
Osiecka BJ; Nockowski P; Szepietowski JC
Acta Derm Venereol; 2018 Jul; 98(7):689-693. PubMed ID: 29963684
[TBL] [Abstract][Full Text] [Related]
17. Randomized, double-blind, prospective study to compare topical 5-aminolaevulinic acid methylester with topical 5-aminolaevulinic acid photodynamic therapy for extensive scalp actinic keratosis.
Moloney FJ; Collins P
Br J Dermatol; 2007 Jul; 157(1):87-91. PubMed ID: 17501954
[TBL] [Abstract][Full Text] [Related]
18. Topical methyl aminolevulinate photodynamic therapy using red light-emitting diode light for multiple actinic keratoses: a randomized study.
Szeimies RM; Matheson RT; Davis SA; Bhatia AC; Frambach Y; Klövekorn W; Fesq H; Berking C; Reifenberger J; Thaçi D
Dermatol Surg; 2009 Apr; 35(4):586-92. PubMed ID: 19309347
[TBL] [Abstract][Full Text] [Related]
19. Protoporphyrin IX formation after application of methyl aminolevulinate on the face and scalp with and without prior curettage.
Heerfordt IM; Bieliauskiene G; Wulf HC
Photodiagnosis Photodyn Ther; 2018 Jun; 22():155-157. PubMed ID: 29601904
[TBL] [Abstract][Full Text] [Related]
20. A Randomized Split-Face Clinical Trial of Photodynamic Therapy with Methyl Aminolevulinate versus Ingenol Mebutate Gel for the Treatment of Multiple Actinic Keratoses of the Face and Scalp.
Zane C; Fabiano A; Arisi M; Calzavara-Pinton P
Dermatology; 2016; 232(4):472-7. PubMed ID: 27578305
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
